newsfilter
← Latest News
Business Wire·

Better Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates

Company obtained FDA authorization for AspyreRxTM to treat adults with type 2 diabetes and announced commercial launch Company to host a conference call and webcast today at 8:30 a.m. ET Better Therapeutics, Inc.